Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
News
Boards
Rpharmy Memorial
Approved Hospital Formulary
Formulary Addition Requisition (Position 1)
Rpharmy Memorial Formweb Change Request (Position 2)
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warning
LASA
Do Not Crush
Therapeutic Interchange
Non-Formulary
REMS
High Cost Drugs
Renal Dosing
Hazardous Drugs
Restricted
Questions & Suggestions (Position 3)
Webpage Links
HIGH ALERT: Please review policy carefully.
×
Search results for:
insulin regular
insulin regular
Drug Name
Form
Strength
Non-Formulary
Restricted
Renal Dosing
REMS
Therapeutic Interchange
Notes
NovoLIN R
SOLUTION, INJECTABLE
human recombinant 100 units/mL
HumuLIN R (Concentrated)
SOLUTION, SUBCUTANEOUS
human recombinant 500 units/mL
VIEW MORE
Short-Acting Insulins
CLASS
68200808
High Alert Drug
:
Policy
Additional Information:
Drug Name
Common Side Effects
insulin regular
low blood sugar: confusion, dizzy, hunger, shaky
weight gain
scarring of fat tissue (lipodystrophy)
Last updated:
Sep. 23, 2022
UpToDate
Recent Citations via Medline (PubMed)
FDA Daily Med Package Inserts
FDA Approved Drug Products
Drugs.com/Pill Identifier
Rhazdrugs:
insulin regular